A cluster randomized controlled non-inferiority trial of 5-day Dose Adjustment for Normal Eating (DAFNE) training delivered over 1 week versus 5-day DAFNE training delivered over 5 weeks: The DAFNE 5 × 1-day trial

Diabetic Medicine

Volumn 32, Issue 3, 2015, Pages 391-398

  Elliott, J ^a   Rankin, D ^b   Jacques, R M ^c   Lawton, J ^b   Emery, C J ^a   Campbell, M J ^c   Dixon, S ^c   Heller, S R ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; TRIACYLGLYCEROL; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIABETES EDUCATION; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; DOSE ADJUSTMENT FOR NORMAL EATING TRAINING; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTENTION TO TREAT ANALYSIS; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; QUALITATIVE RESEARCH; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SELF CARE; AGED; CLINICAL TRIAL; COMPLICATION; COST BENEFIT ANALYSIS; ECONOMICS; EDUCATION; FEEDING BEHAVIOR; INCIDENCE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT EDUCATION; PHYSIOLOGY; PSYCHOLOGY; TIME; TREATMENT OUTCOME;

ADULT; AGED; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 1; EDUCATION; FEEDING BEHAVIOR; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; INCIDENCE; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PSYCHOLOGY; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84922609171     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12621     Document Type: Article

References (24)

1. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 2002; 325: 746-749.
2. Diabetes Education Network. Available at: http://www.diabetes-education.net/index.php?link =education &page=centres. Last accessed 24 March 2014.
3. Department of Health, Structured patient education in diabetes - report from patient education working group, 2005. Available at: http://webarchive.nationalarchives.gov.uk/20130107105354/http:/www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4113195. Last accessed 24 March 2014.
4. Health and Social Care Information Centre. National Diabetes Audit 2010-2011 - Report into the data quality of diabetes structured education. Available at: http://www.hqip.org.uk/assets/NCAPOP-Library/NCAPOP-2012-13/Diabetes-Audit-Report-10-11-StructuredEducation-pub-2012.pdf. Last accessed 24 March 2014.
5. George JT, Valdovinos AP, Russell I, Dromgoole P, Lomax S, Torgerson DJ et al. Clinical effectiveness of a brief educational intervention in Type 1 diabetes: results from the BITES (Brief Intervention in Type 1 diabetes, Education for Self-efficacy) trial. Diabet Med 2008; 25: 1447-1453.
6. Knott J, Ryder J, Jenkins E, Charman J, Shaban C, Cross C et al. A 12-year audit of BERTIE: successful outcomes for at least 5 years [abstract]. Diabet Med 2012; 19 (Suppl 1):21.
7. Lawton J, Rankin D. How do structured education programmes work? A qualitative investigation of the Dose Adjustment for Normal Eating (DAFNE) programme for type 1 diabetes patients in the UK. Soc Sci Med 2010; 71: 486-493.
8. Lawton J, Rankin D, Elliott J. Is Consulting Patients About Their Health Service Preferences a Useful Exercise? Qual Health Res 2013; 23: 876-886.
9. Elliott J, Lawton J, Rankin D, Emery C, Campbell M, Dixon S et al. The 5x1 DAFNE Study Protocol: A cluster randomised trial comparing a standard 5 day DAFNE course delivered over 1 week against DAFNE training delivered over 1 day a week for 5 consecutive weeks. BMC Endocr Disord 2012; 12: 28.
10. The Diabetes Control and Complication Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 683-689.
11. Piaggio G. Elbourne DR, Altman DG, Pocock SJ, Evans S, J for the CONSORT Group. Reporting of noninferiority and equivalence randomized trials. An extension of the CONSORT statement. JAMA 2006; 295: 1152-1160.
12. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. Ann Intern Med 2001; 134: 657-662.
13. Welch GW, Jacobson AM, Polonsky WH. The problem areas in diabetes scale. An evaluation of its clinical utility. Diabetes Care 1997; 20: 760-766.
14. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370.
15. Van Der Ven NC, Weinger K, Yi J, Pouwer F, Ader H, Van Der Ploeg HM et al. The confidence in diabetes self-care scale: psychometric properties of a new measure of diabetes-specific self-efficacy in Dutch and US patients with type 1 diabetes. Diabetes Care 2003; 26: 713-718.
16. Bott U, Muhlhauser I, Overmann H, Berger M. Validation of a diabetes-specific quality-of-life scale for patients with type 1 diabetes. Diabetes Care 1998; 21: 757-769.
17. Cox DJ, Irvine A, Gonder-Frederick L, Nowacek G, Butterfield J. Fear of hypoglycaemia: quantification, validation, and utilization. Diabetes Care 1987; 10: 617-621.
18. Kind P. The EuroQol instrument: an index of health-related quality of life. In: Spilker B ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven, 1996.
19. Hopkins D, Lawrence I, Mansell P, Thompson G, Amiel S, Campbell M et al. Improved Biomedical and Psychological Outcomes 1 Year After Structured Education in Flexible Insulin Therapy for People With Type 1 Diabetes: The U.K. DAFNE experience. Diabetes Care 2012; 35: 1638-1642.
20. Elliott J, Jacques R, Kruger J, Campbell M, Amiel S, Mansell P et al. Substantial reduction in episodes of diabetic ketoacidosis and savings in emergency treatment costs following structured education in patients with Type 1 diabetes. Diabet Med 2014; 31: 847-853.
21. Lawton J, Rankin D, Cooke D, Clarke M, Elliott J, Heller S. Dose Adjustment For Normal Eating: a qualitative longitudinal exploration of the food and eating practices of type 1 diabetes patients converted to flexible intensive insulin therapy in the UK. Diabetes Res Clin Pract 2011; 91: 87-93.
22. Dinneen SF, O'Hara MC, Byrne M, Smith D, Courtney CH, McGurk C et al. Group follow-up compared to individual clinic visits after structured education for type 1 diabetes: A cluster randomised controlled trial. Diabetes Res Clin Pract 2013; 100: 29-38.
23. Cooke D, Bond R, Lawton J, Rankin D, Heller S, Clark M et al. Structured type 1 diabetes education delivered within routine care: impact on glycemic control and diabetes-specific quality of life. Diabetes Care 2013; 36: 270-272.
24. Speight J, Amiel SA, Bradley C, Heller S, Oliver L, Roberts S et al. Long-term biomedical and psychosocial outcomes following DAFNE (Dose Adjustment for Normal Eating) structured education to promote intensive insulin therapy in adults with sub-optimally controlled type 1 diabetes. Diabetes Res Clin Pract 2010; 89: 22-29.